おかえりなさい
Click “ログイン” to agree to Cointime’s 利用規約 and acknowledge that Cointime’s プライバシーポリシー applies to you.
アカウント登録
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">利用規約</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">プライバシーポリシー</a> applies to you.
siteでログインする
siteで登録する
あなたのメールアドレス
受信トレイを確認する
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Silexon
company
About
Silexon is an AI-based pharmaceutical research and development service provider.
- 1 - 10
Highlights
Details
- Last Funding Type
- Series A
- Industries
- Artificial Intelligence,Machine Learning
- Founded date
- Jan 1, 2018
- Number Of Employee
- 1 - 10
- Operating Status
- Active
Silexon is an AI drug research and development service provider. It is committed to the systematic integration of drug big data using artificial intelligence methods, and deep-enhanced drug development process, specifically involving drug target panorama report, personalized cell therapy, and small molecule virtual screening.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
—
Silexon has raised a total of
—
in funding over 2 rounds. Their latest funding was raised on
Oct 17, 2019 from a Series A round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Oct 17, 2019 | Series A | — | 2 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
2
Silexon is funded by 2 investors.
Shengding Equity Investment Fund
and Prosperico Ventures
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
— | Series A |
Prosperico Ventures
|
— | Series A |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
